Creativity Awards Class of 2011
The Ben Franklin-PCF Creativity Award
Niphatenones a Completely New Class of Androgen Receptor Antagonist
Marianne Sadar, PhD
Senior Scientist, Michael Smith Genome Sciences Centre, BC Cancer Agency
Honorary Associate Professor, Department of Pathology and Laboratory Medicine
University of British Columbia
The Ben Franklin-PCF Creativity Award
Prospective Translational Study of XL184, a Dual Inhibitor of VEGFR2 and MET, in Men with Castration-Resistant Prostate Cancer (CRPC) and Bone Metastases
Matthew R. Smith, MD, PhD
Associate Professor, Department of Medicine, Harvard Medical School
Assistant in Medicine, Hematology/Oncology
Massachusetts General Hospital Cancer Center
The Ben Franklin-PCF Creativity Award
Target identification Combining In Vivo Tissue Transformation with Multi-parameter Profiling and “Surprisal Analysis”
Owen Witte, MD
Distinguished Professor of Microbiology, Immunology, and Molecular Genetics
President’s Chair in Developmental Immunology
David Geffen School of Medicine
University of California, Los Angeles
The Ben Franklin-PCF Creativity Award
The Mesenchymal-to-Epithelial Transition (MET) as a Novel Target for Treatment of Disseminated (Metastatic) Prostate Cancer
Bruce Zetter, PhD
Professor of Cancer Biology, Department of Surgery
Harvard Medical School
Dana-Farber/Harvard Cancer Center